Watson Pharmaceuticals searches for two new presidents

Share this article:
Watson Pharmaceuticals announced it has initiated a search for two newly created president positions for each of the Corona, Calif.-based company's business units – brands and generics.
As a result of this new management structure, Joseph Papa, Watson's chief operating officer and president, will leave the company Nov. 19.
"Following our decision in June to focus on generics and specialty brand products, including urology and nephrology, we have continued to implement strategies to increase our focus in these specialty areas," said Allen Chao, Watson's chief executive. "We believe having a president in each business unit will enhance our ability to maximize the growth of each business."
Share this article:

Email Newsletters

More in News

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.

Eli Lilly and BI's Jardiance hits shelves

Eli Lilly and BI's Jardiance hits shelves

The new SGLT-2 inhibitor is on shelves less than a month after FDA approval.

PhRMA Urges Court to Reject Off-Label Promotion Case

PhRMA Urges Court to Reject Off-Label Promotion Case

The Pharmaceutical Research and Manufacturers of America (PhRMA) says a California federal court should dismiss a whistleblower's False Claims Act suit against three drug companies on First Amendment grounds